WHWK
Whitehawk Therapeutics, Inc.
Next earnings Aug 5, 2026 · consensus $-0.31 EPS
Last earnings -5.1% on 2026-05-07
$4.11▲ +96.65%
over 1Y
L $1.60EODHDH $5.10
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W-7.0%
1M-13.8%
3M+15.1%
YTD+68.4%
1Y+96.7%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy
Conservative balance sheet (liabilities/equity 0.11x); but revenue fell -72.5% YoY.
Whitehawk Therapeutics, Inc. shows $7.14M in FY2025 revenue (-72.5% YoY), a -288.3% net margin, and -15.1% ROE.
Sources: SEC EDGAR (CIK 0001422142, latest 10-Q filed 2026-05-07) · as of 6/26/2026, 6:32:45 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.